Navigation Links
Inverness Medical Innovations to Present at the UBS Global Life Sciences Conference on September 22, 2008
Date:9/19/2008

WALTHAM, Mass., Sept. 19 /PRNewswire-FirstCall/ -- Inverness Medical Innovations, Inc. (Amex: IMA), a leading manufacturer and marketer of rapid diagnostic products for the consumer and professional markets, today announced that Ron Zwanziger, Chairman, Chief Executive Officer and President, and Jon Russell, Vice President, Finance, are scheduled to attend the UBS Global Life Sciences Conference being held September 22-25, 2008 at the Grand Hyatt New York in New York City. The Company's presentation is scheduled for 1:00 p.m. on Monday, September 22, 2008 and will be made available to the public through an audio webcast accessible at http://www.ibb.ubs.com . A replay of the webcast will be available via the link above for 30 days. During its presentation, Inverness may discuss and answer questions concerning business and financial developments and trends. Responses to questions, as well as other matters discussed during the webcast, may contain or constitute information that has not been disclosed previously.

For more information about Inverness Medical Innovations, please visit our website at http://www.invernessmedical.com .

By developing new capabilities in near-patient diagnosis, monitoring and health management, Inverness Medical Innovations enables individuals to take charge of improving their health and quality of life. A global leader in rapid point-of-care diagnostics, Inverness' products, as well as its new product development efforts, focus on infectious disease, cardiology, oncology, drugs of abuse and women's health. Inverness is headquartered in Waltham, Massachusetts.


'/>"/>
SOURCE Inverness Medical Innovations, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Inverness Medical Innovations to Attend the Goldman Sachs Diagnostics Conference on September 18, 2008
2. Inverness Medical Innovations Declares Dividend on its Series B Convertible Perpetual Preferred Stock
3. Inverness Medical Innovations to Present at the Morgan Stanley Global Healthcare Unplugged Conference on September 9, 2008
4. Inverness Medical Innovations Features Innovative TB Diagnostic - Clearview(R) TB ELISA at AIDS 2008
5. Inverness Medical Innovations to Present at Canaccord Adams 28th Annual Growth Conference on August 12, 2008
6. Inverness Medical Innovations Announces Second Quarter 2008 Results
7. Inverness Medical Innovations to Present at Jefferies 2nd Annual Healthcare Conference held on June 25, 2008
8. Inverness Medical Innovations to Present at 7th Annual Needham & Company, LLC Biotechnology & Medical Technology Conference on June 12, 2008
9. Inverness Medical Innovations to Present at FBR Capital Markets 12th Annual Spring Investor Conference on May 28, 2008
10. Inverness Medical Innovations Completes Acquisition of Matria Healthcare, Inc.
11. Inverness Medical Innovations to Participate at Morgan Stanley Global Healthcare Unplugged Conference on April 30, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... The Pistoia Alliance is ... biomolecular representation standard software toolkit and editor under ... HELM (Hierarchical Editing Language for Macromolecules) enables the ... proteins, nucleotides, antibody drug conjugates) whose size and ... impractical or unusable. HELM solves this problem through ...
(Date:6/18/2013)... ZIONA, Israel , June 18, 2013 /PRNewswire/ ... bulk Active Pharmaceutical Ingredients (APIs), generic and innovative intermediates, and ... today that the company has been granted a ... in the US and Europe for ... Patent number 8,410,176 B2 is titled Intermediate Compounds and ...
(Date:6/18/2013)... , June 18, 2013   Lexicon Pharmaceuticals, ... biopharmaceutical company focused on discovering breakthrough treatments for ... has joined the company as its vice ... Northcott brings extensive commercial experience to Lexicon, including ... variety of therapeutic areas. Mr. Northcott ...
(Date:6/18/2013)... Minneapolis, MN (PRWEB) June 18, 2013 ... the Saniclave 200 prevent the dangers of ... confusing features, like knobs, analog pressure gauges, hot surfaces ... older autoclave, or a new, modern autoclave, Revolutionary Science ... use fresh water. Older autoclave designs will recycle ...
Breaking Biology Technology:The Pistoia Alliance Releases HELM Biomolecular Representation Standard Open Source Tools 2Mapi Pharma Granted United States Patent for Pain Relief Medication "Tapentadol" 2John Northcott Joins Lexicon as Vice President of Marketing, Commercial Strategy and Operations 2John Northcott Joins Lexicon as Vice President of Marketing, Commercial Strategy and Operations 3How to Autoclave: Why the User Friendliness of the Saniclave 200 is So Important Today 2
... The United States Food & Drug,Administration (FDA) today approved a ... HIV-1 Group M RNA, hepatitis C RNA and hepatitis B,DNA ... TaqScreen MPX,Test for use on the cobas s 201 system, ... HIV-1 Group M RNA, HIV-1 Group O RNA,HIV-2 RNA, hepatitis ...
... Common Stock to Remain Listed While it , ... Technologies, Inc. (NYSE Alternext US: PTN) today reported it ... formerly known as the American Stock Exchange), advising Palatin ... of the Exchange,s continued listing standards under Section 1003 ...
... Biosciences Corporation (Nasdaq: MATK ) announced today that ... 11th Annual Growth Conference in New York City. The ... York Palace Hotel. Peter L. Buzy, CFO will be ... Time.A live audio webcast of Martek,s presentation can be accessed ...
Cached Biology Technology:FDA Approves Most Comprehensive System to Test Donated Blood for HIV, Hepatitis B & Hepatitis C 2FDA Approves Most Comprehensive System to Test Donated Blood for HIV, Hepatitis B & Hepatitis C 3Palatin Technologies Receives Notification Letter from NYSE Alternext US 2Palatin Technologies Receives Notification Letter from NYSE Alternext US 3
(Date:6/18/2013)... 2013 Joshua Obar, Ph.D., Department of Immunology and ... a 2013 ICAAC Young Investigator Award for his research ... responses to infection. , Obar earned his B.A. ... went on to complete his Ph.D. in Microbiology and ... his Ph.D. thesis research in Edward Usherwood,s laboratory at ...
(Date:6/18/2013)... The herbal extract of a yellow-flowered mountain plant long ... lifespan of fruit fly populations by an average of ... it,s how Rhodiola rosea , also ... attention of study leaders Mahtab Jafari and Sam Schriner. ... manner completely unrelated to dietary restriction and affects different ...
(Date:6/18/2013)... DNA and this modification can occur in millions ... scientists believed that this epigenetic phenomenon actively reduced ... of researchers from the University of Geneva (UNIGE), ... the Faculty of Medicine, reveals that this is ... may play both a passive and active role ...
Breaking Biology News(10 mins):The American Society for Microbiology honors Joshua Obar 2Herbal extract boosts fruit fly lifespan by nearly 25 percent, UCI study finds 2The secret of DNA methylation 2
... mediating the outcome of competition between rival groups, as ... New World--or, on a much smaller ecological scale, the ... bacteria. In a new study, researchers have compared two ... another, and they have found that each strategy seems ...
... health professionals and the general public alike have been acutely ... flu pandemic. Although many people might still recall the pandemics ... the possibility of a recurrence on that scale--that causes the ... know exactly how many people died from this particular strain ...
... energy save us from global warming? Perhaps, but the ... nuclear waste generated each year and a greatly increased ... material into terrorists' hands. , So concludes University ... how much nuclear power would need to be produced ...
Cached Biology News:Different strategies underlie the ecology of microbial invasions 2Recurrence of a flu pandemic similar to infamous 1918 flu could kill 62 million 2Recurrence of a flu pandemic similar to infamous 1918 flu could kill 62 million 3Plutonium or greenhouse gases? Weighing the energy options 2
... cultured in DMEM and harvested at the log ... the antigens in their native forms, cells were ... on a 12-well (5 mm) adhesive coated slide, ... cellular attachment and to minimize background staining. ...
... CopyControl™ vector can be induced prior to ... provide the stability of single-copy BACs with ... other cloning vectors. The kits provide the ... insert size screening system) necessary to create ...
... / 3T3 cells were cultured in DMEM with ... phase of growth. In order to keep ... fixed in acetone-methanol. The cells are arrayed ... with each wells surface specifically treated to enhance ...
... The CopyControl™ vector can be induced prior ... vectors provide the stability of single-copy BACs ... or other cloning vectors. The kits provide ... reagents, insert size screening system) necessary to ...
Biology Products: